AGC
Aspen Grove Capital’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
34,883
+841
| +2% | +$32.7K | 0.23% | 57 |
|
|
2025
Q1 | $1.33M | Buy |
34,042
+3,258
| +11% | +$128K | 0.26% | 60 |
|
|
2024
Q4 | $1.05M | Sell |
30,784
-1,470
| -5% | -$50.3K | 0.22% | 61 |
|
|
2024
Q3 | $1.33M | Sell |
32,254
-7
| -0% | -$289 | 0.29% | 54 |
|
|
2024
Q2 | $1.25M | Buy |
32,261
+64
| +0.2% | +$2.49K | 0.3% | 54 |
|
|
2024
Q1 | $1.39M | Hold |
32,197
| – | – | 0.39% | 49 |
|
|
2023
Q4 | $1.2M | Buy |
32,197
+174
| +0.5% | +$6.51K | 0.37% | 53 |
|
|
2023
Q3 | $1.17M | Buy |
32,023
+146
| +0.5% | +$5.34K | 0.44% | 47 |
|
|
2023
Q2 | $1.14M | Buy |
31,877
+705
| +2% | +$25.2K | 0.37% | 61 |
|
|
2023
Q1 | $1.11M | Buy |
31,172
+1,164
| +4% | +$41.5K | 0.49% | 47 |
|
|
2022
Q4 | $1.06M | Buy |
+30,008
| New | +$1.06M | 0.49% | 47 |
|